Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 831,208 | 395,356 | 1,765,667 | 1,318,003 | 877,910 |
| Accounts payable and accrued liabilities | -698,527 | -375,628 | -1,495,669 | -1,152,538 | -781,755 |
| Other Working Capital | 111,951 | 6,398 | 196,421 | 116,489 | 69,403 |
| Other Operating Activity | -132,769 | -19,755 | -275,048 | -168,924 | -98,647 |
| Operating Cash Flow | $111,863 | $6,371 | $191,371 | $113,030 | $66,911 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,685 | 831 | 1,106 | 2,880 | 10,473 |
| PPE Investments | -33,395 | -18,667 | -84,809 | -62,729 | -39,584 |
| Net Acquisitions | -33,805 | -441 | -53,014 | -18,069 | -17,110 |
| Purchase Sale Intangibles | -5,360 | 0 | -4,000 | -3,400 | -675 |
| Other Investing Activity | -5,255 | 5,561 | -9,390 | -3,950 | -5,932 |
| Investing Cash Flow | $-70,770 | $-12,716 | $-146,107 | $-81,868 | $-52,153 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 294,750 | N/A | 1,600 | N/A | N/A |
| Debt Repayment | -3,585 | -1,882 | -11,589 | -9,349 | -4,414 |
| Common Stock Issued | 4,396 | 1,896 | 12,912 | 10,471 | 6,371 |
| Other Financing Activity | -4,456 | -2,057 | 3,408 | 3,287 | 1,719 |
| Financing Cash Flow | $291,105 | $-2,043 | $6,331 | $4,409 | $3,676 |
| Exchange Rate Effect | -3,248 | -3,266 | -8,835 | -3,708 | 3,445 |
| Beginning Cash Position | 204,524 | 204,524 | 161,764 | 161,764 | 161,764 |
| End Cash Position | 533,474 | 192,870 | 204,524 | 193,627 | 183,643 |
| Net Cash Flow | $328,950 | $-11,654 | $42,760 | $31,863 | $21,879 |
| Free Cash Flow | |||||
| Operating Cash Flow | 111,863 | 6,371 | 191,371 | 113,030 | 66,911 |
| Capital Expenditure | -33,395 | -18,667 | -84,809 | -62,729 | -39,584 |
| Free Cash Flow | 78,468 | -12,296 | 106,562 | 50,301 | 27,327 |